Lysosomal storage disease overview
Обзор лизосомных болезней накопления
2018-12-01
SCID: 54.1/25jvtatm
Discuss with AI
enzyme deficienciesenzyme replacement therapyinherited metabolic disorderslysosomal storage diseasesmucopolysaccharidoses
Figures from the paper
Abstract (AI)
The lysosomal storage diseases (LSDs) are a group of inherited metabolic disorders that are caused for the most part by enzyme deficiencies within the lysosome resulting in accumulation of undegraded substrate. This storage process leads to a broad spectrum of clinical manifestations depending on the specific substrate and site of accumulation. Examples of LSDs include the mucopolysaccharidoses, mucolipidoses, oligosaccharidoses, Pompe disease, Gaucher disease, Fabry disease, the Niemann-Pick disorders, and neuronal ceroid lipofuscinoses. This review summarizes the main clinical features, diagnosis, and management of LSDs with an emphasis on those for which treatment is available.
Key Findings
1
Lysosomal storage diseases are primarily inherited metabolic disorders caused by lysosomal enzyme deficiencies and accumulation of undegraded substrates.
2
Particular emphasis is placed on LSDs for which therapeutic treatments are currently available.
3
Substrate accumulation produces diverse clinical manifestations determined by the specific stored material and its anatomical site.
4
The LSD spectrum includes mucopolysaccharidoses, mucolipidoses, oligosaccharidoses, Pompe, Gaucher, Fabry, Niemann-Pick, and neuronal ceroid lipofuscinosis disorders.
5
The review summarizes the principal clinical features, diagnostic approaches, and management strategies for lysosomal storage diseases.
Research Object
lysosomal storage diseases (LSDs)
Research Subject
clinical features, diagnosis, and management of LSDs, with emphasis on treatable disorders
Publication Details
Publication Date
2018-12-01
Journal
Publisher
ISSN
Cited by
281
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest